Highlights
KLSE: PHARMA (7081)       PHARMANIAGA BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
0.705   -0.01 (1.40%)  0.70 - 0.715  3,284,300
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 923 Million

Market Cap 923 Million
NOSH 1,309 Million

Latest Audited Result:  31-Dec-2020

Latest Audited Result: 31-Dec-2020
Announcement Date 24-May-2021
Next Audited Result: 31-Dec-2021
Est. Ann. Date: 24-May-2022
Est. Ann. Due Date: 29-Jun-2022

Latest Quarter:  30-Sep-2021 [#3]

Latest Quarter: 30-Sep-2021 [#3]
Announcement Date 19-Nov-2021
Next Quarter: 31-Dec-2021
Est. Ann. Date: 17-Mar-2022
Est. Ann. Due Date: 01-Mar-2022
QoQ | YoY   263.65%  |    3,355.96%

Annual (Unaudited) ( EPS: 2.10, P/E: 33.57 )

Revenue | NP to SH 2,725,071  |  27,489
RPS | P/RPS 208.16 Cent  |  0.34
EPS | P/E | EY 2.10 Cent  |  33.57  |  2.98%
DPS | DY | Payout % 2.20 Cent  |  3.12%  |  104.63%
NAPS | P/NAPS 0.26  |  2.74
YoY   118.42%
NP Margin | ROE 0.96%  |  8.15%
F.Y. | Ann. Date 31-Dec-2020  |  17-Mar-2021

T4Q Result ( EPS: 6.14, P/E: 11.49 )

Revenue | NP to SH 4,737,880  |  80,344
RPS | P/RPS 361.91 Cent  |  0.19
EPS | P/E | EY 6.14 Cent  |  11.49  |  8.71%
DPS | DY | Payout % 4.50 Cent  |  6.38%  |  73.30%
NAPS | P/NAPS 0.30  |  2.36
QoQ | YoY   151.46%  |    155.49%
NP Margin | ROE 1.69%  |  20.53%
F.Y. | Ann. Date 30-Sep-2021  |  19-Nov-2021

Annualized Result ( EPS: 8.83, P/E: 7.99 )

Revenue | NP to SH 5,471,062  |  115,566
RPS | P/RPS 417.92 Cent  |  0.17
EPS | P/E | EY 8.83 Cent  |  7.99  |  12.52%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   56.85%  |    156.28%
NP Margin | ROE 2.12%  |  29.52%
F.Y. | Ann. Date 30-Sep-2021  |  19-Nov-2021


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2021 19-Nov-2021 30-Sep-2021 3 4,737,880 138,481 79,993 80,344 58,895 391,428 73.30% 1.69% 20.53% 1,309,126 361.91 361.91 6.14 6.14 4.50 4.50 0.2990 0.30   151.46%   155.49% 30-Sep-2021 0.835 0.23 13.61 2.79 7.35% 5.39% 19-Nov-2021 0.845 0.23 13.77 2.83 7.26% 5.32%
31-Dec-2021 20-Aug-2021 30-Jun-2021 2 3,230,009 44,355 30,963 31,951 36,634 357,275 114.66% 0.96% 8.94% 1,308,702 246.81 246.73 2.44 2.44 2.80 2.80 0.2730 0.27   13.20%   121.92% 30-Jun-2021 5.29 2.14 216.68 19.38 0.46% 0.53% 20-Aug-2021 0.925 0.37 37.89 3.39 2.64% 3.03%
31-Dec-2021 21-May-2021 31-Mar-2021 1 2,698,649 36,437 26,682 28,226 23,534 355,919 83.38% 0.99% 7.93% 261,705 1,031.18 206.14 10.79 2.16 9.00 1.80 1.3600 0.27   2.68%   119.28% 31-Mar-2021 3.26 0.32 30.23 2.40 3.31% 2.76% 21-May-2021 4.03 0.39 37.37 2.96 2.68% 2.23%
31-Dec-2020 17-Mar-2021 31-Dec-2020 4 2,725,071 35,793 26,269 27,489 28,740 337,298 104.55% 0.96% 8.15% 261,472 1,042.20 208.16 10.51 2.10 11.00 2.20 1.2900 0.26   118.99%   118.42% 31-Dec-2020 5.00 0.48 47.56 3.88 2.10% 2.20% 17-Mar-2021 3.49 0.33 33.20 2.71 3.01% 3.15%
31-Dec-2020 19-Nov-2020 30-Sep-2020 3 2,806,171 -189,175 -145,417 -144,778 26,125 345,040 - % -5.18% -41.96% 261,394 1,073.54 214.35 -55.39 -11.06 10.00 2.00 1.3200 0.26   0.66%   -528.13% 30-Sep-2020 4.32 0.40 -7.80 3.27 -12.82% 2.31% 19-Nov-2020 5.72 0.53 -10.33 4.33 -9.68% 1.75%
31-Dec-2020 19-Aug-2020 30-Jun-2020 2 2,898,216 -189,383 -146,335 -145,739 22,204 357,891 - % -5.05% -40.72% 261,235 1,109.43 221.39 -55.79 -11.13 8.50 1.70 1.3700 0.27   0.48%   -401.20% 30-Jun-2020 2.22 0.20 -3.98 1.62 -25.13% 3.83% 19-Aug-2020 4.42 0.40 -7.92 3.23 -12.62% 1.92%
31-Dec-2020 19-May-2020 31-Mar-2020 1 2,854,343 -191,228 -146,680 -146,437 22,188 350,047 - % -5.14% -41.83% 261,229 1,092.66 218.03 -56.06 -11.19 8.50 1.69 1.3400 0.27   1.86%   -429.08% 31-Mar-2020 1.26 0.12 -2.25 0.94 -44.49% 6.75% 19-May-2020 1.88 0.17 -3.35 1.40 -29.82% 4.52%
31-Dec-2019 20-Feb-2020 31-Dec-2019 4 2,820,530 -191,865 -149,447 -149,219 22,144 336,573 - % -5.30% -44.33% 260,910 1,081.04 215.45 -57.19 -11.40 8.50 1.69 1.2900 0.26   -541.27%   -451.37% 31-Dec-2019 2.06 0.19 -3.60 1.60 -27.76% 4.13% 20-Feb-2020 2.04 0.19 -3.57 1.58 -28.04% 4.17%
31-Dec-2019 20-Nov-2019 30-Sep-2019 3 2,701,491 58,549 33,856 33,816 27,347 516,387 80.87% 1.25% 6.55% 260,802 1,035.84 206.36 12.97 2.58 10.50 2.09 1.9800 0.39   -30.11%   -43.39% 30-Sep-2019 2.44 0.24 18.82 1.23 5.31% 4.30% 20-Nov-2019 2.21 0.21 17.04 1.12 5.87% 4.75%
31-Dec-2019 23-Aug-2019 30-Jun-2019 2 2,572,302 72,267 48,785 48,386 40,348 518,564 83.39% 1.90% 9.33% 260,585 987.13 196.49 18.57 3.70 15.50 3.08 1.9900 0.40   8.74%   0.26% 28-Jun-2019 2.84 0.29 15.29 1.43 6.54% 5.46% 23-Aug-2019 2.66 0.27 14.33 1.34 6.98% 5.83%
31-Dec-2019 16-May-2019 31-Mar-2019 1 2,553,141 71,756 45,289 44,499 44,226 528,825 99.39% 1.77% 8.41% 260,505 980.07 195.03 17.08 3.40 17.00 3.38 2.0300 0.40   4.78%   -15.06% 29-Mar-2019 2.27 0.23 13.29 1.12 7.53% 7.49% 16-May-2019 2.36 0.24 13.82 1.16 7.24% 7.20%
31-Dec-2018 21-Feb-2019 31-Dec-2018 4 2,384,956 70,220 43,230 42,468 41,587 509,862 97.93% 1.81% 8.33% 260,134 916.82 182.18 16.33 3.24 16.00 3.18 1.9600 0.39   -28.90%   -20.95% 31-Dec-2018 2.78 0.30 17.03 1.42 5.87% 5.76% 21-Feb-2019 2.76 0.30 16.91 1.41 5.92% 5.80%
31-Dec-2018 19-Nov-2018 30-Sep-2018 3 2,401,508 78,146 60,748 59,731 51,957 522,618 86.99% 2.53% 11.43% 260,009 923.62 183.44 22.97 4.56 20.00 3.97 2.0100 0.40   23.77%   91.53% 28-Sep-2018 2.89 0.31 12.58 1.44 7.95% 6.92% 19-Nov-2018 3.09 0.33 13.45 1.54 7.43% 6.47%
31-Dec-2018 17-Aug-2018 30-Jun-2018 2 2,388,351 75,814 49,333 48,260 51,929 519,642 107.60% 2.07% 9.29% 259,821 919.23 182.44 18.57 3.69 20.00 3.97 2.0000 0.40   -7.88%   18.67% 29-Jun-2018 2.88 0.31 15.51 1.44 6.45% 6.94% 17-Aug-2018 3.11 0.34 16.74 1.56 5.97% 6.43%
31-Dec-2018 16-May-2018 31-Mar-2018 1 2,323,589 73,994 53,318 52,386 51,913 524,838 99.10% 2.29% 9.98% 259,821 894.30 177.49 20.16 4.00 20.00 3.97 2.0200 0.40   -2.49%   13.53% 30-Mar-2018 4.28 0.48 21.23 2.12 4.71% 4.67% 16-May-2018 4.07 0.46 20.19 2.01 4.95% 4.91%
31-Dec-2017 27-Feb-2018 31-Dec-2017 4 2,323,960 73,064 54,987 53,723 49,290 526,888 91.75% 2.37% 10.20% 259,551 895.38 177.52 20.70 4.10 19.00 3.77 2.0300 0.40   72.26%   17.82% 29-Dec-2017 4.60 0.51 22.22 2.27 4.50% 4.13% 27-Feb-2018 4.04 0.45 19.52 1.99 5.12% 4.70%
31-Dec-2017 15-Nov-2017 30-Sep-2017 3 2,293,580 57,267 31,999 31,187 41,490 531,892 133.04% 1.40% 5.86% 259,460 883.98 175.20 12.02 2.38 16.00 3.17 2.0500 0.41   -23.31%   -50.10% 29-Sep-2017 4.14 0.47 34.44 2.02 2.90% 3.86% 15-Nov-2017 3.82 0.43 31.78 1.86 3.15% 4.19%
31-Dec-2017 16-Aug-2017 30-Jun-2017 2 2,234,292 61,919 40,757 40,668 38,883 542,147 95.61% 1.82% 7.50% 259,400 861.33 170.67 15.68 3.11 15.00 2.97 2.0900 0.41   -11.87%   -41.41% 30-Jun-2017 4.58 0.53 29.21 2.19 3.42% 3.28% 16-Aug-2017 4.19 0.49 26.73 2.00 3.74% 3.58%
31-Dec-2017 16-May-2017 31-Mar-2017 1 2,248,121 73,256 46,647 46,143 41,456 544,360 89.84% 2.07% 8.48% 259,219 867.27 171.73 17.80 3.52 16.00 3.17 2.1000 0.42   1.19%   -34.67% 31-Mar-2017 4.89 0.56 27.47 2.33 3.64% 3.27% 16-May-2017 4.72 0.54 26.52 2.25 3.77% 3.39%
31-Dec-2016 21-Feb-2017 31-Dec-2016 4 2,189,022 72,017 45,859 45,599 41,442 531,169 90.88% 2.09% 8.58% 259,107 844.83 167.21 17.60 3.48 16.00 3.17 2.0500 0.41   -27.04%   -45.74% 30-Dec-2016 5.30 0.63 30.12 2.59 3.32% 3.02% 21-Feb-2017 5.05 0.60 28.70 2.46 3.48% 3.17%
31-Dec-2016 21-Nov-2016 30-Sep-2016 3 2,286,356 91,665 62,800 62,497 51,803 531,250 82.89% 2.75% 11.76% 259,146 882.26 174.65 24.12 4.77 20.00 3.96 2.0500 0.41   -9.96%   -40.30% 30-Sep-2016 5.58 0.63 23.14 2.72 4.32% 3.58% 21-Nov-2016 5.70 0.65 23.64 2.78 4.23% 3.51%
31-Dec-2016 19-Aug-2016 30-Jun-2016 2 2,295,554 97,079 70,127 69,407 64,750 524,177 93.29% 3.05% 13.24% 258,981 886.38 175.35 26.80 5.30 25.00 4.95 2.0240 0.40   -1.73%   -30.36% 30-Jun-2016 5.50 0.62 20.52 2.72 4.87% 4.55% 19-Aug-2016 5.62 0.63 20.97 2.78 4.77% 4.45%
31-Dec-2016 13-May-2016 31-Mar-2016 1 2,276,603 100,648 71,128 70,629 69,935 515,906 99.02% 3.12% 13.69% 258,859 879.48 173.90 27.28 5.40 27.00 5.34 1.9930 0.39   -15.96%   -28.96% 31-Mar-2016 5.76 0.65 21.11 2.89 4.74% 4.69% 13-May-2016 5.60 0.64 20.52 2.81 4.87% 4.82%
31-Dec-2015 15-Feb-2016 31-Dec-2015 4 2,189,312 112,722 84,584 84,044 77,704 529,786 92.46% 3.86% 15.86% 259,064 845.08 167.23 32.44 6.42 30.00 5.94 2.0450 0.40   -19.71%   -10.44% 31-Dec-2015 6.36 0.75 19.60 3.11 5.10% 4.72% 15-Feb-2016 6.19 0.73 19.08 3.03 5.24% 4.85%
31-Dec-2015 26-Nov-2015 30-Sep-2015 3 2,136,265 126,859 105,164 104,679 90,625 534,373 86.57% 4.92% 19.59% 259,027 824.73 163.18 40.41 8.00 35.00 6.92 2.0630 0.41   5.03%   34.27% 30-Sep-2015 6.50 0.79 16.08 3.15 6.22% 5.38% 26-Nov-2015 6.50 0.79 16.08 3.15 6.22% 5.38%
31-Dec-2015 17-Aug-2015 30-Jun-2015 2 2,113,938 126,467 100,190 99,663 88,011 528,477 88.31% 4.74% 18.86% 259,057 816.01 161.48 38.47 7.61 34.00 6.72 2.0400 0.40   0.24%   49.29% 30-Jun-2015 7.13 0.87 18.53 3.50 5.40% 4.77% 17-Aug-2015 5.65 0.69 14.69 2.77 6.81% 6.02%
31-Dec-2015 18-May-2015 31-Mar-2015 1 2,126,165 126,033 99,505 99,421 80,234 528,173 80.70% 4.68% 18.82% 258,908 821.20 162.41 38.40 7.59 31.00 6.13 2.0400 0.40   5.94%   75.51% 31-Mar-2015 6.00 0.73 15.62 2.94 6.40% 5.17% 18-May-2015 6.91 0.84 17.99 3.39 5.56% 4.49%
31-Dec-2014 23-Feb-2015 31-Dec-2014 4 2,122,933 125,580 94,225 93,844 72,463 525,351 77.22% 4.44% 17.86% 258,794 820.32 162.16 36.26 7.17 28.00 5.54 2.0300 0.40   20.37%   70.01% 31-Dec-2014 4.58 0.56 12.63 2.26 7.92% 6.11% 23-Feb-2015 5.28 0.64 14.56 2.60 6.87% 5.30%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 2,063,690 120,733 78,871 77,960 57,457 507,124 73.70% 3.82% 15.37% 258,737 797.60 157.64 30.13 5.96 22.20 4.39 1.9600 0.39   16.78%   194.71% 30-Sep-2014 4.63 0.58 15.37 2.36 6.51% 4.79% 21-Nov-2014 4.45 0.56 14.77 2.27 6.77% 4.99%
31-Dec-2014 21-Aug-2014 30-Jun-2014 2 2,002,411 109,249 68,040 66,756 44,519 502,293 66.69% 3.40% 13.29% 258,914 773.39 152.96 25.78 5.10 17.20 3.40 1.9400 0.38   17.85%   39.22% 30-Jun-2014 4.61 0.60 17.88 2.38 5.59% 3.73% 21-Aug-2014 4.62 0.60 17.92 2.38 5.58% 3.72%
31-Dec-2014 14-May-2014 31-Mar-2014 1 1,914,972 94,232 58,254 56,646 42,973 515,022 75.86% 3.04% 11.00% 258,805 739.93 146.28 21.89 4.33 16.61 3.28 1.9900 0.39   2.62%   -1.99% 31-Mar-2014 4.46 0.60 20.38 2.24 4.91% 3.72% 14-May-2014 4.70 0.64 21.47 2.36 4.66% 3.53%
31-Dec-2013 24-Feb-2014 31-Dec-2013 4 1,946,639 92,997 56,761 55,200 41,446 486,672 75.08% 2.92% 11.34% 258,868 751.98 148.70 21.32 4.22 16.01 3.17 1.8800 0.37   108.67%   -10.55% 31-Dec-2013 4.45 0.59 20.87 2.37 4.79% 3.60% 24-Feb-2014 4.29 0.57 20.12 2.28 4.97% 3.73%
31-Dec-2013 19-Nov-2013 30-Sep-2013 3 1,861,183 64,238 28,026 26,453 37,168 473,402 140.51% 1.51% 5.59% 258,689 719.47 142.17 10.23 2.02 14.37 2.84 1.8300 0.36   -44.83%   -67.58% 30-Sep-2013 4.82 0.67 47.14 2.63 2.12% 2.98% 19-Nov-2013 4.72 0.66 46.16 2.58 2.17% 3.04%
31-Dec-2013 16-Aug-2013 30-Jun-2013 2 1,846,836 79,270 49,392 47,949 41,172 480,568 85.87% 2.67% 9.98% 258,370 714.80 141.07 18.56 3.66 15.94 3.15 1.8600 0.37   -17.04%   -28.60% 28-Jun-2013 4.49 0.63 24.19 2.41 4.13% 3.55% 16-Aug-2013 4.66 0.65 25.11 2.51 3.98% 3.42%
31-Dec-2013 15-May-2013 31-Mar-2013 1 1,865,940 97,283 59,298 57,797 41,189 484,829 71.27% 3.18% 11.92% 117,676 1,585.65 142.53 49.11 4.41 35.00 3.15 4.1200 0.37   -6.34%   -11.57% 29-Mar-2013 8.26 0.52 16.82 2.00 5.95% 4.24% 15-May-2013 9.26 0.58 18.85 2.25 5.30% 3.78%
31-Dec-2012 18-Feb-2013 31-Dec-2012 4 1,812,346 103,314 63,206 61,711 41,188 472,037 66.74% 3.49% 13.07% 117,715 1,539.60 138.44 52.42 4.71 35.00 3.15 4.0100 0.36   -24.36%   18.32% 31-Dec-2012 8.10 0.53 15.45 2.02 6.47% 4.32% 18-Feb-2013 7.80 0.51 14.88 1.95 6.72% 4.49%
31-Dec-2012 06-Nov-2012 30-Sep-2012 3 1,697,728 115,434 82,856 81,587 64,713 496,469 79.32% 4.88% 16.43% 117,646 1,443.07 129.68 69.35 6.23 55.00 4.94 4.2200 0.38   21.50%   114.93% 28-Sep-2012 7.55 0.52 10.89 1.79 9.19% 7.28% 06-Nov-2012 8.25 0.57 11.90 1.95 8.41% 6.67%
31-Dec-2012 08-Aug-2012 30-Jun-2012 2 1,642,700 102,587 68,279 67,151 52,948 481,394 78.85% 4.16% 13.95% 117,700 1,395.66 125.48 57.05 5.13 44.99 4.04 4.0900 0.37   2.74%   87.92% 29-Jun-2012 10.18 0.73 17.84 2.49 5.60% 4.42% 08-Aug-2012 8.83 0.63 15.48 2.16 6.46% 5.09%
31-Dec-2012 03-May-2012 31-Mar-2012 1 1,582,398 94,349 66,247 65,358 44,120 474,161 67.51% 4.19% 13.78% 117,657 1,344.91 120.87 55.55 4.99 37.50 3.37 4.0300 0.36   25.31%   78.76% 30-Mar-2012 5.90 0.44 10.62 1.46 9.42% 6.36% 03-May-2012 5.90 0.44 10.62 1.46 9.42% 6.36%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 1,520,981 73,186 52,785 52,157 35,296 514,153 67.67% 3.47% 10.14% 117,655 1,292.74 116.18 44.33 3.98 30.00 2.70 4.3700 0.39   37.40%   71.66% 30-Dec-2011 5.36 0.41 12.09 1.23 8.27% 5.60% 22-Feb-2012 5.90 0.46 13.31 1.35 7.51% 5.08%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  5 people like this.
 
Cipta wow! The new Bstead Chairman very powerful! Just One week appointment already win 10 years contract for its subsidiary. Who say flying car can not fly? ^_^ Wish Pharma fly high like Flying Car in year 2022!!!. Wish those bler & ei can win a lot money and need not holiday in KLSEi3 forum at year end but can have proper vocation in Dubai this year! Bravo New Year! Roar!!!!
12/01/2022 9:43 AM
chowwei Wa Lao Er
Sell On News
12/01/2022 11:40 AM
chowwei 哎哟 不错噢 救星到
HLIB 把它救了上来
12/01/2022 12:33 PM
Cyber_moneyman Huat ah.. kasi goreng Pharma kaw²
12/01/2022 6:34 PM
Cyber_moneyman Kasi CNY Ang Pow
12/01/2022 6:34 PM
chowwei 机会是留给 有信心的人
13/01/2022 9:30 AM
VTrade Ppv say sinox3 will take the 4th
14/01/2022 10:59 AM
chowwei 上个星期 星期一
都是 Sell On News
17/01/2022 11:03 AM
chowwei 看来看去 又朝向 0.695
HLIB 不给大力 顶着它
19/01/2022 9:40 AM
chowwei 最近 股市 大红
每天 跟你跌 10点
问你 怕了没
马股 很难 找到吃
19/01/2022 10:03 AM
chowwei 股市 很无情
完全不给 散户
一条生路 过年
19/01/2022 5:36 PM
kfliau 步步惊心!
19/01/2022 5:37 PM
CT Lew Current market needs to trade carefully.
19/01/2022 5:38 PM
kfliau @chowwei 你现在还要谢谢pharma老板吗?
20/01/2022 7:59 AM
Trevor777 Yes, Mr Liau, these people would never listen or see Facts and Figures even when history tells the truth.

Anyway, they are only small kids playing shares for the 1st time, buying only 200 to 300 units for fun. But they sure talk damn big!

They only lose peanuts or gets locked at same price for years.
20/01/2022 8:58 AM
Cipta From recent development, do you still confident on Malaysia SC?

If you are not confident to market regulator on Insider Trading, fake account, misleading info & justly, will you believe Bursa, GLC will hold higher moral ground than SC?

Last week so optimism, shout confident, must trust, good will, reward on good fate; this week moan, shout run, pain, beg to the Croc to give a life line. So cheap a soul who emotion totally controlled by others. Wake up! Think independently!
20/01/2022 10:16 AM
chowwei 耐心成金 时间是 最好良药
20/01/2022 2:56 PM
Trevor777 不见棺材,不流泪
20/01/2022 3:16 PM
Trevor777 Just realised I'm responding to a kid who only bought 200-300 units for fun from his year end bonus! Waste of time.

Let him be locked here at 70c for years.
20/01/2022 3:25 PM
chowwei 慢慢进场 1年 进4次
目标 400,000 Units
目前 216,000 Units
20/01/2022 9:04 PM
chowwei 要写几 Units 人家才会 看懂
如果写 / 几张 / 几粒 / 看不懂
20/01/2022 9:07 PM
chowwei 买 200-300 Units
比如股价是 0.730
200 Units = RM146
300 Units = RM219
只是给水钱都亏死你
21/01/2022 1:36 AM
chowwei 放着它 5年 到 10年
等 再次重来 以前辉煌
21/01/2022 2:08 PM
kfliau 等到花儿也谢了
21/01/2022 7:47 PM
Trevor777 如果相信你拥有216,000 units,母猪可以爬树。
22/01/2022 8:59 AM
chowwei 216,000 Units 大概是 RM170,000
现在 马来西亚 东西那么贵 不算有钱人
22/01/2022 12:34 PM
chowwei 发马 216,000 Units 大概是 RM170,000 左右
现在 马来西亚 东西 变那么贵 不算是有钱人
22/01/2022 12:36 PM
Trevor777 有钱人也不用等年终红利买股!

有人说屁话.
22/01/2022 1:29 PM
Trevor777 USA, deaths due to Covid : more than 850,000 lives

China, deaths due to Covid : more than 4,000

Who is lying?
22/01/2022 1:31 PM
miqie21 China’s zero tolerance policy is very effective.
22/01/2022 7:23 PM
周 海 China is using 'zero tolerance policy' to show its advantage against democratic policies. I thought China has given up the 'zero tolerance policy' a few days ago? By renaming it to something like economic....
22/01/2022 7:33 PM
Legend Pfizer Inc chief executive Albert Bourla said on Saturday that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.

Pfizer-BioNtech’s Covid-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant but less effective in preventing transmission.

With cases soaring, some countries have expanded Covid-19 vaccine booster programmes or shortened the gap between shots as governments scramble to shore up protection.

In an interview with Israel’s N12 News, Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis.

“This will not be a good scenario. What I’m hoping (is) that we will have a vaccine that you will have to do once a year,” Bourla said.

“Once a year – it is easier to convince people to do it. It is easier for people to remember.

“So from a public health perspective, it is an ideal situation. We are looking to see if we can create a vaccine that covers Omicron and doesn’t forget the other variants and that could be a solution,” Bourla said.

Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March.

Citing three studies, the US Centers for Disease Control and Prevention said on Friday that a third dose of an mRNA vaccine is key to fighting Omicron, providing 90% protection against hospitalisation.

A preliminary study published by Israel’s Sheba Medical Center on Monday found that a fourth shot increases antibodies to even higher levels than the third but was likely not enough to fend off Omicron. Nonetheless, a second booster was still advised for risk groups, Sheba said.
23/01/2022 9:26 AM
Cipta Zero Risk Management or Risk Management?

Which is suitable to Malaysia?

Is taking vaccine is a Zero Risk?
If NOT, why take risk to jap since the country is operating in Zero Risk Management.
If YES, And it is effective, and it covers 95% of your population, then the risk should be very low close to normal sickness like flu. Nothing to scare of.

Instead of milking the pharmaceutical companies in huge profit, why not finding the nature HOST ? China has every advantage to find the natural host. With China Speed, sure can find its natural antibody.

**Reminder: A Malaysian Doctor had found the Nipah natural host in only one month 24 years ago.
24/01/2022 8:53 AM
chowwei 如果 现在有人
愿意买 119.1 张
股价就会 冲破 0.740
24/01/2022 10:51 AM
Trevor777 傻子, 你慢慢等....
24/01/2022 1:22 PM
chowwei https://youtu.be/3Y_e8O4ZLgg
RM4200 股息 除于 RM20 等于 210 张股票
https://youtu.be/3Y_e8O4ZLgg
24/01/2022 3:12 PM
chowwei Trevor777
拍 Video 然后 Copy Link 在这里
让我看看 猪怎样爬上树
我吃到那么大 真的没看过 猪爬上树
24/01/2022 3:15 PM
chowwei Trevor777
拍个 Video 然后 Copy Link 到这里
让我开眼界看看 猪到底是怎样爬上树 因为
我吃到那么大 只是听过传说中而已
还没有真正 看过 猪爬上树
24/01/2022 3:19 PM
Trevor777 所以你是, "眼大不见山"
24/01/2022 3:55 PM
chowwei 我不在意 什么 不见猪 不见山 不见海
我只在意 公司要赚大钱 和 公司不会倒闭
24/01/2022 4:52 PM
Cipta https://www.malaysiakini.com/news/608559
27/01/2022 8:51 AM
Cipta Placebo = non protection. Which vaccine you guess most likely if it is true?
27/01/2022 8:53 AM
Cipta https://www.freemalaysiatoday.com/category/nation/2022/01/27/pharmaniaga-chairman-shazalli-redesignated-as-non-independent-director/
27/01/2022 4:08 PM
Cipta UMNO division head is the new Pharma chairman. Go go withdraw your EPF to buy Pharma share. It "will" up to RM2. HOLD it until your cucu give birth your cicit.

This is a Good company. Good products. Good Management. The most important question is: Is it GOOD to you?

Let's see who is the Tiger who is the Goat. Roar~~~~~~
27/01/2022 4:34 PM
kfliau All these political appointees are fleecing the company dry, like felda
27/01/2022 10:59 PM
Karma4444 Umno will help pharmaniaga
28/01/2022 11:38 AM
kfliau Ya, will help it become PN17, lol
28/01/2022 11:47 AM
Trevor777 That Lan-head talked so much, now ran off with tail between legs...hahaha

Die already or not? 70c only.
28/01/2022 12:17 PM
Cipta Since the announcement, from the share price can see Market gives vote of no-confidence.
28/01/2022 8:03 PM
JJPTR RENONG was UMNO COUNTER
SUMATEC UMNO COUNTERS
MRCB UMNO COUNTERS
ALL BECOME NO MO COUNTERS
28/01/2022 8:10 PM